This study aimed to evaluate the feasibility and safety of online MR-guided single-fraction stereotactic ablative radiotherapy (SABR) and to assess acute changes in pulmonary function tests (PFTs), inflammatory markers, patient-reported quality of life (QoL), and dosimetric outcomes.
